Brief: Decibel Therapeutics Reports Q2 Results
10/08/2021 12:51
Aug 10 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS INC - QUARTERLY NET LOSS $11.7
MILLION
VERSUS LOSS $7.8 MILLION
* DECIBEL THERAPEUTICS - BELIEVES THAT EXISTING CASH, CASH
EQUIVALENTS, AVAILABLE-FOR-SALE SECURITIES WILL FUND PIPELINE
PROGRAMS AND OPERATING EXPENSES INTO 2024
Source text for Eikon: ID:nGNX5dTnx2
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary